MIAMI & TORONTO–(BUSINESS WIRE)- March 30th, 2022 -Flora Growth Corp. (NASDAQ: FLGC) (“Flora” or the “Company”), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced today that the Company’s Chairman and CEO Luis Merchan is the keynote speaker at the Plant Medicine Week conference held at the Mediterranean Conference Centre in Valletta, Malta, from April 5-8.
Merchan’s keynote speech at the conference, entitled, “Malta – The Gateway to South American and European Cannabis Relations,” will be held at 2:30 CET and will address the opportunity presented by Malta’s stance on cannabis, the cost advantages of South American cultivation, and the broader European opportunity.
The Plant Medicine Week conference in Malta allows industry professionals and attendees to gain a diverse and inspiring perspective on the latest advances in the cannabis and psychedelics industries through a mix of exhibitions, presentations, discussions, and Q&A sessions.
“I’m honored to be keynote speaker at the Plant Medicine Week conference this year in Malta,” Flora Growth CEO Luis Merchan said. “I look forward to sharing our expertise as a global cultivator and distributor in the international cannabis space and continuing to foster our relationship with the country of Malta, a leader in Europe’s cannabis trade.”
Flora Growth intends to schedule meetings with interested media and other parties to discuss the opportunity of cannabis in the EU, the industry’s need for more sustainable cultivation practices, and Flora’s growth strategy more broadly. To schedule a meeting with Luis Merchan, Chairman and CEO of Flora Growth, please contact Cassandra Dowell via email at firstname.lastname@example.org.
About Flora Growth Corp.
Flora is building a connected, design-led collective of plant-based wellness and lifestyle brands designed to deliver the most compelling customer experiences in the world, one community at a time. As the operator of one of the largest outdoor cannabis cultivation facilities, Flora leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. Visit www.floragrowth.com or follow @floragrowthcorp on social media for more information.
Cautionary Statement Concerning Forward-Looking Statements
This document contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: expected future revenue, the proposed acquisition of Vessel; Vessel’s financial performance; our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of the Company; our ability to keep pace with new technology and changing market needs; and the competitive environment of our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this document and other statements made from time to time by us or our representatives may not occur, and actual events and results may differ materially and are subject to risks, uncertainties and assumptions about us. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of uncertainties and assumptions, or the forward-looking events discussed in this document and other statements made from time to time by us or our representatives not occurring, except as may be required by applicable law.